Antibiotic resistance: Understanding how to control it

International Journal of Antimicrobial Agents

Volumn 40, Issue 3, 2012, Pages 193-195

  Gould, Ian M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Carbapenemases; ESBLs; ITS; MRSA; TSA

Indexed keywords

CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; FOSFOMYCIN; MACROLIDE; PLEUROMUTILIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CULTURE TECHNIQUE; DRUG DOSE REGIMEN; DRUG SCREENING; HAND WASHING; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCHIP ANALYSIS; MONOTHERAPY; NONHUMAN; PERSONAL HYGIENE; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84864595995     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.05.020     Document Type: Article

References (21)

1. World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva, Switzerland: WHO; 2012. http://whqlibdoc.who.int/publications/2012/9789241503181-eng.pdf [accessed 11.05.12].
2. R. Jain, S.M. Kralovic, M.E. Evans, M. Ambrose, L.A. Simbarti, and D.S. Obrosky Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections N Engl J Med 364 2011 1419 1430
3. T. Gurieva, M.C.J. Bootsma, and M.J.M. Bonten Successful Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections revisited Clin Infect Dis 54 2012 1618 1620
4. D.H. Wyllie, A.S. Walker, R. Miller, C. Moore, S.R. Williamson, and I. Schlackow Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification BMJ Open 1 2011 e000160
5. J.M. Lopez-Lozano, and T. Lawes Things may not be as they seem. Response to Wyllie et al. 'Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification' BMJ Open 1 2011 e000160
6. T. Lawes, B. Edwards, J.-M. López-Lozano, and I.M. Gould Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis BMJ Open 2 2012 e000797
7. Lawes T, Gould IM. Dissecting a multi-intervention MRSA prevention bundle may miss emergent properties. Clin Infect Dis, 2012; http://dx.doi.org/10.1093/ cid/cis602, forthcoming.
8. D.J. Hetem, H. Westh, K. Boye, Jarlov, M.J.M. Bonten, and M.C.J. Bootsma Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus in Danish hospitals J Antimicrob Chemother 67 2012 1775 1780
9. B.T. Tsuji, Y. Harigaya, A.J. Lesse, G. Sakoulas, and J.M. Mylotte Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia Diagn Microbiol Infect Dis 64 2009 220 224
10. J.K. Rudkin, A.M. Edwards, M.G. Bowden, E.L. Brown, C. Pozzi, and E.M. Waters Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system J Infect Dis 205 2012 798 806
11. V. Thati, S.T. Channappa, and G.M. Subhaschandra Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad Indian J Med Res 134 2011 704 708
12. X.M. Wang, W.J. Zhang, S. Stefan, S.Y. Yu, H. Liu, and W. Si Methicillin-resistant Staphylococcus aureus ST9 from a case of bovine mastitis carries the genes cfr and erm(A) on a small plasmid J Antimicrob Chemother 67 2012 1287 1289
13. P. Davey, E. Brown, L. Fenelon, R. Finch, I. Gould, and G. Hartman Interventions to improve antibiotic prescribing practices for hospital inpatients Cochrane Database Syst Rev 2005 CD003543
14. A. de Jong, V. Thomas, S. Simjee, K. Godinho, B. Schiessi, and U. Klein Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals J Antimicrob Chemother 67 2012 638 651
15. E. Koratzanis, M. Souli, I. Galani, Z. Chryssouli, and A. Armaganidis Epidemiology and molecular characterisation of metallo-β-lactamase- producing Enterobacteriaceae in a university hospital intensive care unit in Greece Int J Antimicrob Agents 38 2011 390 397
16. D.M. Livermore, M. Warner, S. Mushtaq, M. Doumith, J. Zhang, and N. Woodford What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline Int J Antimicrob Agents 37 2011 415 419
17. N. Petrosillo, E. Ioannidou, and M.E. Falagas Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies Clin Microbiol Infect 14 2008 816 827
18. S. Pournaras, G. Vrioni, E. Neou, J. Dendrinos, E. Dimitroulia, and A. Poulou Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay Int J Antimicrob Agents 37 2011 244 247
19. D.M. Livermore, J.M. Andrews, P.M. Hawkey, P.L. Ho, Y. Keness, and Y. Doi Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 67 2012 1569 1577
20. S. Mushtaq, M. Warner, G. Williams, I. Critchley, and D.M. Livermore Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae J Antimicrob Chemother 65 2010 1428 1432
21. I.M. Gould Coping with antibiotic resistance: the impending crisis Int J Antimicrob Agents 36 Suppl. 3 2010 S1 S2